ImmunoTargets and Therapy (Mar 2020)
Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
Abstract
Noha Mousaad Elemam,1 Suad Hannawi,2 Azzam A Maghazachi1 1College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates; 2Ministry of Health and Prevention, Department of Rheumatology, Dubai, United Arab EmiratesCorrespondence: Azzam A MaghazachiCollege of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab EmiratesEmail [email protected]: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases and a prototypic inflammatory disease, affecting the small joints of the hands and feet. Chemokines and chemokine receptors play a critical role in RA pathogenesis via immune cells recruitment. Several chemokines and chemokine receptors are abundant in the peripheral blood and in the local inflamed joints of RA. Furthermore, synthetic and biologics disease modifying anti rheumatic drugs have been reported to affect chemokines expression. Thus, many studies have focused on targeting chemokines and chemokine receptors, where some have shown positive promising results. However, most of the chemokine blockers in human trials of RA treatment displayed some failures that can be attributed to several reasons in their structures and binding affinities. Nevertheless, targeting chemokines will continue to be under development, in order to improve their therapeutic potentials in RA and other autoimmune diseases. In this review we provide an up-to-date knowledge regarding the role of chemokines and chemokine receptors in RA with an emphasis on their activities on immune cells. We also discussed the effects of drugs targeting those molecules in RA. This knowledge might provide impetus for developing new therapeutic modalities to treat this chronic disease.Keywords: rheumatoid arthritis, chemokines, immunotherapy, immunotargets, chemokine receptors, drugs
